Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $28,450 | 8 | 44.8% |
| Travel and Lodging | $21,062 | 7 | 33.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,424 | 3 | 18.0% |
| Honoraria | $2,200 | 1 | 3.5% |
| Food and Beverage | $362.11 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $19,331 | 5 | $0 (2024) |
| F. Hoffmann-La Roche AG | $16,481 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $11,200 | 5 | $0 (2022) |
| PFIZER INC. | $8,904 | 3 | $0 (2021) |
| bioMerieux Inc | $5,582 | 3 | $0 (2024) |
| Sumitomo Dainippon Pharma Co., Ltd. | $2,000 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,642 | 4 | bioMerieux Inc ($5,582) |
| 2023 | $15,171 | 1 | Shionogi Inc ($15,171) |
| 2022 | $5,200 | 1 | GlaxoSmithKline, LLC. ($5,200) |
| 2021 | $13,154 | 7 | GlaxoSmithKline, LLC. ($6,000) |
| 2020 | $3,750 | 1 | PFIZER INC. ($3,750) |
| 2019 | $20,581 | 7 | F. Hoffmann-La Roche AG ($16,481) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2024 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $60.25 | General |
| 05/14/2024 | bioMerieux Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,720.00 | General |
| 05/14/2024 | bioMerieux Inc | — | Travel and Lodging | Cash or cash equivalent | $380.28 | General |
| 05/13/2024 | bioMerieux Inc | — | Travel and Lodging | Cash or cash equivalent | $481.80 | General |
| 12/01/2023 | Shionogi Inc | — | Travel and Lodging | Cash or cash equivalent | $15,170.89 | General |
| 07/13/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| 11/15/2021 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,954.00 | General |
| 11/03/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 08/13/2021 | Sumitomo Dainippon Pharma Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CNS | ||||||
| 07/22/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/15/2021 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $2,200.00 | General |
| 04/14/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 01/12/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/09/2020 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| 12/03/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Consulting Fee | Cash or cash equivalent | $11,250.00 | General |
| Category: None | ||||||
| 12/03/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $4,658.49 | General |
| Category: None | ||||||
| 12/03/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $301.86 | General |
| Category: None | ||||||
| 12/03/2019 | F. Hoffmann-La Roche AG | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $270.67 | General |
| Category: None | ||||||
| 01/16/2019 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/16/2019 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $63.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 01/16/2019 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $36.92 | General |
| Category: Infections and Infectious Diseases | ||||||
About Dr. John Rex, MD
Dr. John Rex, MD is a Infectious Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306151162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rex, MD has received a total of $63,498 in payments from pharmaceutical and medical device companies, with $5,642 received in 2024. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($28,450).
Practice Information
- Specialty Infectious Disease
- Location Houston, TX
- Active Since 08/17/2010
- Last Updated 08/17/2010
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306151162
Products in Payments
- Non-Covered Product (Drug) $16,481
- Fetroja (Drug) $4,100
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Houston
Dr. Richard Hamill, M.d, M.D
Infectious Disease — Payments: $883,001
Roy Chemaly, M.d, M.D
Infectious Disease — Payments: $815,305
Dr. Joseph Gathe, M.d, M.D
Infectious Disease — Payments: $774,683
Ben Barnett, M.d, M.D
Infectious Disease — Payments: $515,688
Dr. Amar Safdar, M.d, M.D
Infectious Disease — Payments: $309,168
Dr. Luis Ostrosky, M.d, M.D
Infectious Disease — Payments: $242,843